Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study
- Conditions
- Management of Stable Vitiligo
- Interventions
- Procedure: platelet rich plasma, narrow band UVB
- Registration Number
- NCT06370650
- Lead Sponsor
- Sohag University
- Brief Summary
For each patient, one side of body will be treated with NB-UVB alone while the other side will be treated with NB-UVB therapy in addition to intradermal injection of PRP every 2 weeks. Patients will be photographed at the first visit, in the middle and at the end of therapy. Each patient will sign a written consent form to be included in the study and to be photographed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Patients with stable non segmental vitiligo. (Absence of koebnerization, absence of new lesion and absence of widening of the existing lesions).
Patients have more than 15 years.
Patients have active vitiligo (appearance of new lesion, history of koebnerization).
Pregnant and lactating women. History of keloid formation. Anemia (hemoglobin level <10gm/dl), thrombocytopenia (platelet count <100,000 /µL), coagulopathies or patients on anticoagulant therapy and patients with iron deficiency.
Patients taking drugs that prolong bleeding time such as Aspirin and vitamin E Patients taking treatment of vitiligo in last 2 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Narrow band UVB platelet rich plasma, narrow band UVB - Platelet rich plasma plus narrow band UVB platelet rich plasma, narrow band UVB -
- Primary Outcome Measures
Name Time Method Improvement of vitiligo within 6 months increase repigmentation score
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Faculty of Medicine, Sohag University
🇪🇬Sohag, Egypt